XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating Activities:    
Net income (loss) $ 21,133 $ (43,977)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Impairment of goodwill 38,138 0
Impairment of long-lived assets 20,433 0
Depreciation and amortization 3,489 2,832
(Accretion of discounts) amortization of premium on marketable securities (1,048) 164
Amortization and other changes in operating lease right-of-use assets 2,092 2,106
Stock-based compensation 8,277 7,691
Net changes in operating assets and liabilities:    
Interest receivable (229) (7)
Accounts receivable (3,348) (925)
Prepaid expenses and other assets 6,223 (241)
Accounts payable and other accrued liabilities (1,905) 3,609
Accrued compensation and employee benefits (8,599) (8,270)
Deferred revenues (149,766) (21,004)
Lease liabilities (1,212) (972)
Other non-current liabilities 22 19
Net cash used in operating activities (66,300) (58,975)
Investing Activities:    
Purchases of marketable securities (36,225) (65,756)
Maturities of marketable securities 82,153 70,300
Purchases of property and equipment (10,200) (2,839)
Net cash provided by investing activities 35,728 1,705
Financing Activities:    
Taxes paid related to net share settlement of equity awards (1,109) (1,641)
Proceeds from exercise of stock options 0 74
Net cash provided by (used in) financing activities 8,002 (1,567)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 367 222
Net decrease in cash, cash equivalents, and restricted cash (22,203) (58,615)
Cash, cash equivalents, and restricted cash, beginning of period 101,944 180,372
Cash, cash equivalents, and restricted cash, end of period 79,741 121,757
Supplemental cash flow disclosures:    
Property and equipment included in unpaid liabilities 5,184 2,257
Tenant improvement allowance included in contra-lease liability 243 0
At the Market Offering    
Financing Activities:    
Proceeds from at-the market offering/ issuance of common stock $ 9,111 $ 0